Expertise in
1
conditions

Andrew H. Strickland

Monash Health
Clayton, VIC, AU 
Expertise in
1
conditions
Monash Health
Clayton, VIC, AU 

Overview

Andrew Strickland practices practicing medicine in Clayton, Australia.

Mr. Strickland is highly rated in 1 condition, according to our data. His clinical expertise encompasses Colorectal Cancer, Stomach Cancer, Pancreatic Ductal Adenocarcinoma, and Pancreatic Cancer.

He is actively involved in clinical research, co-authoring 33 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Monash Health
Clayton, VIC, Australia
Other Locations
Monash, SA, Australia
Frankston, VIC, Australia
Clayton, QLD, Australia
Melbourne, VIC, Australia
Newcastle, NSW, Australia
WA, Australia
Bentleigh, VIC, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers - An International, Multi-Center, Double Blind, Randomized Placebo Controlled Phase III Trial
Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers - An International, Multi-Center, Double Blind, Randomized Placebo Controlled Phase III Trial
Enrollment Status: Unknown
Publish Date: February 02, 2024
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
A Phase III Open-label, Multicenter Trial of Maintenance Therapy With Avelumab (MSB0010718C) Versus Continuation of First-line Chemotherapy in Subjects With Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro-esophageal Junction
A Phase III Open-label, Multicenter Trial of Maintenance Therapy With Avelumab (MSB0010718C) Versus Continuation of First-line Chemotherapy in Subjects With Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro-esophageal Junction
Enrollment Status: Completed
Publish Date: June 09, 2022
Intervention Type: Drug, Other
Study Phase: Phase 3
An Open Label, Single Arm Pilot Study of OncoSil™, Administered to Study Participants With Unresectable Locally Advanced Pancreatic Adenocarcinoma, Given in Combination With FOLFIRINOX or Gemcitabine+Nab-paclitaxel Chemotherapies
An Open Label, Single Arm Pilot Study of OncoSil™, Administered to Study Participants With Unresectable Locally Advanced Pancreatic Adenocarcinoma, Given in Combination With FOLFIRINOX or Gemcitabine+Nab-paclitaxel Chemotherapies
Enrollment Status: Completed
Publish Date: July 13, 2021
Intervention Type: Device
Study Phase: Not Applicable
View 2 Less Clinical Trials

33 Total Publications

Prognostic value of KRAS gene mutations in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.
Prognostic value of KRAS gene mutations in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.
Journal: Scandinavian journal of gastroenterology
Published: January 13, 2026

Frequently Asked Questions about Andrew H. Strickland

Is Andrew H. Strickland a top-rated expert for Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Andrew H. Strickland is classified as an Advanced expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Andrew H. Strickland participate in research or clinical trials?

Yes. Andrew H. Strickland has published 33 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Andrew H. Strickland's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Strickland's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile